ChartMill assigns a Buy % Consensus number of 88% to CGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-21 | Truist Securities | Maintains | Buy -> Buy |
| 2024-03-08 | Truist Securities | Maintains | Buy -> Buy |
| 2023-12-19 | Stifel | Maintains | Buy -> Buy |
| 2023-08-23 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-07 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-06 | EF Hutton | Reiterate | Buy |
| 2023-05-26 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-24 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-02-28 | Oppenheimer | Reiterate | Outperform |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-11-15 | Oppenheimer | Maintains | Outperform |
| 2022-08-23 | Truist Securities | Maintains | Buy |
| 2022-08-08 | JMP Securities | Maintains | Market Outperform |
| 2022-08-08 | Oppenheimer | Maintains | Outperform |
| 2022-08-05 | Jefferies | Downgrade | Buy -> Hold |
| 2022-02-25 | Oppenheimer | Maintains | Outperform |
| 2022-02-25 | SVB Leerink | Maintains | Outperform |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
10 analysts have analysed CGEN and the average price target is 5.92 USD. This implies a price increase of 225.05% is expected in the next year compared to the current price of 1.82.
The consensus rating for COMPUGEN LTD (CGEN) is 88 / 100 . This indicates that analysts generally have a positive outlook on the stock.